VPN Plus+ ExclusiveAn in-depth look at treating diabetes mellitus in catsJuly 28, 2022Cats with diabetes mellitus present some unique challenges, and management strategies for feline diabetics are considerably different from those recommended for their canine counterparts. Practitioners need to understand the processes that drive this disease in cats, and strive to create plans tailored to the specific needs of both the patient and the owner. Recommendations regarding best practices have changed substantially over the last 20 years, and have impacted how diabetic cats are fed, treated, and monitored.
SPONSORED CONTENTStart Treating Canine MMVD Patients at Stage B2Learn about early treatment with pimobendan for canine Stage B2 preclinical MMVD patients. + Learn More
Six facts you need to know about hyperthyroidismNovember 4, 2021There are several important things a practitioner needs to know about hyperthyroidism (HT) before treatment is chosen and begun.
Zomedica announces therapeutic development milestonesDecember 13, 2017Zomedica Pharmaceuticals Corp. veterinary pharmaceutical and diagnostic company announced a development update on the company's four therapeutic candidates for use in companion animals, namely dogs and cats. ZM-012 and ZM-007: Metronidazole for acute diarrhea in dogs Development milestones for ZM-012 and ZM-007, complementary oral formulations of metronidazole targeting the treatment of acute diarrhea in dogs include: Finalized novel tablet formulation for ZM-012 to replace the large, bitter tasting human-approved generic tablet commonly prescribed by veterinarians for their canine patients. The beef-flavored oral tablets are intended for dogs greater than 9 pounds or 4 kilograms. Finalized the oral suspension formulation for ZM-007, which is intended for small breeds and puppies under 9 pounds or 4 kilograms. Completed pilot testing for both formulations at Michigan State University College of Veterinary Medicine to measure metronidazole's effectiveness to treat acute diarrhea in dogs. Scheduled December 2017 pre-submission meeting with the U.S. Food and Drug Administration Center for Veterinary Medicine (FDA-CVM) to present the regulatory strategy and development plan for ZM-012. A safety study will commence for ZM-012 in the first half of 2018 for completion in the second half of 2018. The company also expects to hold a pre-submission …
